(INCR.U) – Company Press Releases
-
InterCure Provides an Update Regarding the Security Situation in Israel
-
InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY
-
InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE
-
InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
-
InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference
-
InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY
-
InterCure to Be Featured with Mike Tyson in an Exclusive Interview on Fox Business
-
InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary
-
InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel
-
InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries
-
InterCure Reschedules 2022 Full Year Results Conference Call
-
InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results
-
InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger
-
InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)
-
InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"
-
InterCure to Participate in Cowen 5th Annual Cannabis Conference
-
InterCure Announces the Withdrawal of a Class Action Lawsuit against it
-
Update regarding Better Transaction
-
Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
-
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies
-
CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
-
InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth
-
InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY
-
Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders
-
InterCure Reports Record Breaking Second Quarter Financial Results
-
InterCure to Release its Q2 2022 Results and Hold a Conference Call
-
InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth
-
InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria
-
InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel
-
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
-
InterCure to Release its Q1 2022 Results and Hold a Conference Call
-
InterCure to Participate in Upcoming Investor Conferences in May 2022
-
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
-
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results
-
InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022
-
CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
-
InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
-
InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
-
InterCure to Hold 2021 Q4 & Year-End Webcast
-
InterCure and Clever Leaves Announce International Strategic Partnership
-
InterCure to Participate in ROTH Capital’s 34th Annual Conference
-
InterCure Announces Partnership with Altman Health
-
InterCure Signs Definitive Agreement to Acquire Multi-National Medical Cannabis Producer “Better”
-
InterCure Reports Record Preliminary 2021 Fourth Quarter Revenue - 3 Times YoY and 24% QoQ Growth
-
InterCure Announces European Expansion with International Cannabis Brand Cookies
-
International Cannabis Brand Cookies and InterCure Announce European Expansion
-
InterCure to Participate in Cowen’s 4th Annual Cannabis Conference
-
InterCure Announces Record Third Quarter Financial Results with 3 Times YoY Revenue Growth and 36% QoQ Growth
-
InterCure Expands Pharmacy Chain in Israel; Surpasses One-Ton Medical Cannabis Products Dispensed Per Month
-
InterCure Schedules Third Quarter 2021 Financial Results Conference Call
Back to INCR.U Stock Lookup
